These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 813934)

  • 61. New data on the effect of azathioprine at the cellular level.
    Galanaud P; Crevon MC; Duclos H; Dormont J
    Adv Nephrol Necker Hosp; 1976; 6():371-82. PubMed ID: 65908
    [No Abstract]   [Full Text] [Related]  

  • 62. [Intercellular information transfer in the process of immunogenesis. VI. The induction of antiphage antibody synthesis in the cells of rat transplantable lymphosarcoma under the influence of splenic RNA from rats and mice immunized with phage T2].
    Pogodina ON; Aksenova NN; Figel'man ML; Fel' VIa
    Tsitologiia; 1979 Apr; 21(4):452-8. PubMed ID: 377738
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The mechanism of K cell (antibody-dependent) cell mediated cytotoxicity. I. The release of different cell components.
    Sanderson CJ; Thomas JA
    Proc R Soc Lond B Biol Sci; 1977 Jul; 197(1129):407-15. PubMed ID: 18738
    [No Abstract]   [Full Text] [Related]  

  • 64. Antibody mediated neutralization of immunosuppression induced by mastocytoma ascites fluids.
    Watanabe M; Pan S; Friedman H
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):238-41. PubMed ID: 79184
    [No Abstract]   [Full Text] [Related]  

  • 65. Letter: Cytotoxicity after B.C.G. infection.
    Koszinowski U; Volkmann B
    Lancet; 1974 Mar; 1(7856):508. PubMed ID: 4131909
    [No Abstract]   [Full Text] [Related]  

  • 66. Absence of enhancing antibody in cell mediated immunity to tumour heterografts in protein deficient rats.
    Jose DG; Good RA
    Nature; 1971 Jun; 231(5301):323-5. PubMed ID: 4996061
    [No Abstract]   [Full Text] [Related]  

  • 67. Tumor immunity.
    Siegel BV; Cohen S
    Fed Proc; 1978 Jul; 37(9):2212-4. PubMed ID: 658461
    [No Abstract]   [Full Text] [Related]  

  • 68. Liberation of non-specific cytotoxic factors during the establishment of immunity against a murine allogeneic tumour.
    Vaillier D; Donner M; Vaillier J; Burg C
    Int Arch Allergy Appl Immunol; 1972; 43(6):871-8. PubMed ID: 4660315
    [No Abstract]   [Full Text] [Related]  

  • 69. Different effector cell types in antibody-dependent cell-mediated cytotoxicity.
    Sanderson CJ; Clark IA; Taylor GA
    Nature; 1975 Jan; 253(5490):376-7. PubMed ID: 803302
    [No Abstract]   [Full Text] [Related]  

  • 70. Effect of host sensitization to tumour on splenic depletion & recovery following severe immunosuppressive treatment.
    Poduval TB; Seshadri M; Ray PK; Thakur VS; Sundaram K
    Indian J Exp Biol; 1979 Oct; 17(10):1064-7. PubMed ID: 546740
    [No Abstract]   [Full Text] [Related]  

  • 71. Mechanisms of "cytostasis" of tumours in vitro by syngeneic lymphoid cells of tumour bearers.
    Farram E; Festenstein H
    Cell Immunol; 1979 May; 44(2):352-66. PubMed ID: 455478
    [No Abstract]   [Full Text] [Related]  

  • 72. Experimental models with possible implications for the role of HLA in malignancy.
    Williams RM
    Prog Clin Biol Res; 1977; 16():21-8. PubMed ID: 410036
    [No Abstract]   [Full Text] [Related]  

  • 73. The effect of cholesterol oleate treatment of mice on the rosette forming cell response against sheep erythrocytes.
    Smith II; Dewar AE; Ramage EF; Stuart AE; Adams W
    Q J Exp Physiol Cogn Med Sci; 1976 Jan; 61(1):45-55. PubMed ID: 1051691
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Murine neuroblastoma cured in vivo by an antibody-dependent cellular cytotoxicity reaction.
    Byfield JE; Zerubavel R; Fonkalsrud EW
    Nature; 1976 Dec 23-30; 264(5588):783-5. PubMed ID: 1012319
    [No Abstract]   [Full Text] [Related]  

  • 75. The mechanism of K cell (antibody-dependent) cell mediated cytotoxicity. II. Characteristics of the effector cell and morphological changes in the target cell.
    Sanderson CJ; Thomas JA
    Proc R Soc Lond B Biol Sci; 1977 Jul; 197(1129):417-24. PubMed ID: 18739
    [No Abstract]   [Full Text] [Related]  

  • 76. Increased cytolytic activity of a subcellular fraction from mouse liver after B.C.G. infection.
    Ferluga J
    Lancet; 1973 Dec; 2(7844):1476-7. PubMed ID: 4129315
    [No Abstract]   [Full Text] [Related]  

  • 77. Low dose tolerance preventing tumor immunity.
    Kölsch E; Mengersen R; Diller E
    Eur J Cancer (1965); 1973; 9(11-12):879-82. PubMed ID: 4216506
    [No Abstract]   [Full Text] [Related]  

  • 78. Investigation into the immunological effects of miltefosine, a new anticancer agent under development.
    Hilgard P; Kampherm E; Nolan L; Pohl J; Reissmann T
    J Cancer Res Clin Oncol; 1991; 117(5):403-8. PubMed ID: 1890137
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dependence on antigen dose and timing in the immune response of C3H mice to malignant ascites cells.
    Laursen ML; Laursen K
    Immunology; 1980 Jul; 40(3):403-10. PubMed ID: 7429535
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunosuppression by a mouse tumor resembles antigenic competition.
    Cocito CG; Michot B; Radovich J; Talmage DW
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2895-7. PubMed ID: 111246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.